Objective. To investigate urinary fractions of free and peptide forms of pyridinoline crosslinks in arthritis.
Pyridinoline (Pyr), a trifunctional 3-hydroxypyridinium lar matrix through a series of enzymatic and noncross-link [1, 2] , and its minor analogue, deoxypyridinoenzymatic processes [8] . It is known that pyridinoline line (Dpyr) [3] , are two of the non-reducible cross-links.
cross-links occur in type I collagen at two sites of They are believed to be physiologically essential and carboxy-terminal telopeptide to helix and at two sites of necessary to maintain the structure of the collagen fibril amino-terminal telopeptide to helix. During bone resorpnetwork in the matrix of the various tissues [4] . Pyr is tion, Pyr, Dpyr and amino-and carboxy-terminal telodistributed in most collagenous tissues, primarily in peptide of type I collagen including those cross-links are cartilage and bone, while significant amounts of Dpyr excreted into the circulation through collagen degradaare distributed more specifically in bone [5] . In the late tion. It has been reported that 40% of those cross-links 1980s, Pyr and Dpyr were proposed as bone resorption are excreted into urine as free amino acids and 60% as markers [6 ] . Since then, a number of studies have shown peptide-bound form [9] . Therefore, after the hydrolysis that urinary Pyr and Dpyr are more sensitive biochemof urine, Pyr and Dpyr are measured by high-performance ical markers for bone resorption [7] . After newly syntheliquid chromatography (HPLC ) as the total amount of sized collagen is incorporated into bone matrix, Pyr and them. Without the hydrolysis of urine, free forms of Pyr Dpyr are formed following accretion into the extracelluand Dpyr are measured as an amount of amino acids by HPLC or by an immunoassay. Recently, assays for measuring the cross-linked telopeptides of type I collagen and carboxy-terminal cross-linked telopeptides (ICTP) Osteoarthritis group are assayed in serum [12] .
This group consisted of 62 post-menopausal female Urinary excretion of Pyr and Dpyr has been generally patients with OA of knee joints, aged 59-85 yr used as a bone resorption marker. However, because (75.3 ± 8.3) . OA of knee joints was diagnosed on the Pyr is most abundant in cartilage, there has been an basis of clinical symptoms, examination and radiological extensive literature on the levels of urinary pyridinium findings. Anterio-posterior weight-bearing knee X-rays cross-links in patients with arthritis [13] [14] [15] [16] . ICTP has were taken, and evaluated according to the Kellgren been reported to be a marker of collagen turnover in and Lawrence grading scale [21] . The patients who had rheumatoid arthritis (RA) [17, 18] . Recently, the differgrade 0 were excluded. ent fraction ratio of the free to peptide-bound form of Informed consent was obtained from all participants. cross-link excretion in post-menopausal women and
The procedures followed were in accordance with the osteoporotic women was reported [19] . Therefore, in principles of the Declaration of Helsinki in 1975, as patients with arthritis, the fraction ratio of free to revised in 1983. peptide-bound cross-links may differ from that of normal subjects. The aim of this study is to investigate Sample collection and storage the fractions of free and peptide-bound pyridinoline Urine samples were collected between 9:00 and 11:00 cross-links in patients with RA and patients with a.m. from all subjects and patients, and stored at −30°C osteoarthritis (OA) in comparison with pre-and postuntil assay. The frozen urine was thawed and an aliquot menopausal normal women.
was used for the measurement of Pyr and Dpyr by HPLC; the remainder was refrozen in two aliquots, and
Subjects and methods then each was thawed and assayed with each immunoassay. All of the assays were performed within 6 months Normal controls (NC) of sample collection. Fifty-two normal healthy women volunteers were included in this study. They were divided into two Measurement of free and total cross-links by HPLC groups: pre-menopausal group (PRE) and post-
The free form of cross-links was measured without menopausal group (POST ). The pre-menopausal group hydrolysis of urine and the total form was measured consisted of 30 pre-menopausal healthy females who after hydrolysis of urine. Aliquots of urine samples have a regular menstrual cycle, aged 24-50 yr (2 ml ) were hydrolysed with an equal volume of 12  (mean ± .., 41.0 ± 6.4). The post-menopausal group HCl for 20 h at 110°C. Hydrolysates were centrifuged consisted of 23 healthy post-menopausal females, aged and supernatants were used. Pyr and Dpyr were meas-51-69 yr (60.9 ± 4.9). They had had no menstrual bleedured using HPLC directly linked to an ASPEC ing for at least 1 yr since their last menstruation.
(Automated Sample Preparation with Extraction The time since menopause ranges from 1 to 14 yr Columns) system which was an automatic sample prep-(mean ± .., 4.7 ± 3.2). All subjects had no previous aration system [22] . Briefly, the ASPEC system consisted history of metabolic bone diseases and were receiving of a Model ASPEC XL sampler, a Model 401C dilutor no medications affecting calcium absorption and metaand a keypad controller (all from Gilson, France). For bolism. The subjects who had OA were excluded by the sample preparation, the ASPEC system used solidpresent and past histories of illness.
phase extraction columns containing 100 mg microgranRheumatoid arthritis group ular cellulose (CC31 microgranular cellulose powder; Whatman Biosystems, Ltd, Maidstone, Kent) and This group consisted of 18 pre-menopausal and 20 postacetylpyridinoline, which is an analogue of Pyr, as an menopausal female patients with RA: pre-menopausal internal standard (a gift from Dr Robins, Rowett RA patients aged 36-53 yr (44.9 ± 5.4) and postResearch Institute, Aberdeen). The HPLC system conmenopausal RA patients aged 51-67 yr (57.1 ± 5.1).
sisted of a Model CCPM pump, a Model FS-8010 RA was diagnosed according to the American spectrofluorometer and a Model SC-8010 system Rheumatism Association 1987 revised criteria for the controller (all from TOSOH, Tokyo, Japan). A classification of RA. As a measure of the disease activity Microsorb C18 Short-One column (4.6 × 100 mm; of RA, serum C-reactive protein (CRP) and the Rainin Instrument Co., Inc., Woburn, MA, USA) was Lansbury Index were measured. The Lansbury Index used. The fluorescence at 390 nm was measured on was determined based on duration of morning stiffness, excitation at 297 nm. The external standards of Pyr and erythrocyte sedimentation rate (ESR) (value at 1 h), Dpyr were isolated from the human cortical bone [23] . grip strength (mmHg) and joint score [20] . Joint score
The values of Pyr and Dpyr were corrected by urinary was determined as the sum of scores for painful, tender creatinine measured enzymatically on an autoanalyser or swollen joints [20] . According to their treatment with (COBAS MIRA, Nihon Rosch, Japan). The intra-assay oral steroid, patients were classified as either users or coefficient of variance (CV ) was 6.4% for Pyr and 6.0% non-users. The patients who were treated with oral for Dpyr, and the interassay CV was 5.9% for Pyr and steroids at any time during the last 6 months were defined as users.
6.0% for Dpyr. PRE, pre-menopause; POST, post-menopause; f, free; p, peptide bound; t, total; measured by HPLC; iDpyr, free Dpyr measured by an immunoassay, PYRILINKS-D@; CTx, carboxy-terminal telopeptide of type I collagen.
The cross-links were expressed as nmol/mmol creatinine, except for CTx which was expressed as mg/mmol creatinine. All measurements had a significant difference among groups calculated by Kruskal-Wallis test.
A significance between two groups was determined by the Mann-Whitney U-test. aP < 0.05 vs NC PRE; bP < 0.01 vs NC PRE; cP < 0.05 vs NC POST; dP < 0.01 vs NC POST.
Measurement of cross-links by immunoassays
and total Pyr and iDpyr were significantly higher in RA than in NC. The correlations between the fractions of Free deoxypyridinoline (iDpyr) in urine was measured cross-links and the parameters of RA disease activity using a PYRILINKS-D@ EIA kit from Metra were examined ( Table 2 ). Peptide and total Pyr, and Biosystems Inc. (Palo Alto, CA, USA) [24] . The intrapeptide Dpyr, correlated significantly with CRP. Peptide and interassay CVs were 6.6 and 8.3%, respectively.
Pyr correlated significantly with the Lansbury Index. CTx was assayed by an ELISA kit, CrossLaps@ from
The fractions of cross-links were compared between Osteometer BioTec A/S (Herlev, Denmark) [11] . The steroid users and non-users in RA ( Table 3) . Peptide intra-and interassay CVs were 4.3 and 7.1%, respectand total Pyr tended to be higher in users than nonively. The values of iDpyr and CTx were expressed users in the total of pre-menopausal RA and postper mmol of urinary creatinine.
menopausal RA or in post-menopausal RA. In a comparison between OA and post-menopausal Statistical analysis NC, free Dpyr were significantly lower in OA than in Data were analysed using a StatView II program on a NC, and peptide and total Dpyr tended to be lower Macintosh computer. The statistical significance of ( Table 1) . CTx was significantly lower in OA than in difference was determined with non-parametric statistics post-menopausal NC. Fractions of cross-links and iDpyr using Mann-Whitney U-tests between two groups and and CTx were compared between two groups divided Kruskal-Wallis among more than two groups. Simple by radiographic grading of OA: patients with grade 1-2 regression was performed for univariate correlation and and patients with grade 3-4. Mean ± .. values of the the statistical significance of correlation was determined age of patients with grade 1-2 and those with grade 3-4 with the Spearman rank correlation test. P < 0.05 was were 67.9 ± 8.6 and 73.5 ± 7.2, respectively. The group considered significant. with grade 3-4 had significant greater values of peptide and total Pyr, peptide and total Dpyr, and iDpyr Results compared to the group with grade 1-2 ( Table 4) . Table 1 shows the values (mean ± ..) of free and The measurements were compared between RA and NC. In PRE, all fractions of Pyr, free and total Dpyr, The correlation coefficient (r) was calculated with simple regression and immunoassayed Dpyr (iDpyr) were significantly and the statistical significance of correlation (P) was determined with the Spearman rank correlation test.
higher in RA than in NC ( 104.3 ± 50.2 fDpyr 5.5 ± 2.1 5.1 ± 2.9 5.7 ± 2.4 5.5 ± 2.6 pDpyr 13.6 ± 6.9 11.0 ± 6.6 15.7 ± 6.8 14.0 ± 7.3 tDpyr 19.2 ± 8.7 16.2 ± 8.0 21.4 ± 9.0 19.4 ± 9.0 CRP 5.7 ± 4.0 1.5 ± 1.7a 6.2 ± 4.1 1.8 ± 2.0a Lansbury Index 63.6 ± 19.2 39.3 ± 14.6a 68.7 ± 18.9 39.5 ± 13.5a
PRE, pre-menopausal RA (n = 18); POST, post-menopausal RA (n = 20). Data were expressed as the mean ± .. aP < 0.01 vs user.
T 4. Comparison of the fraction of cross-links between subgroups
The ratios of free to total (f/t) Pyr and Dpyr in the divided by OA grading groups are presented in Fig. 1 . There was a significant difference in f/t Pyr (P = 0.0001) and f/t Dpyr f/t ratio tended to be lower in POST than in PRE. fDpyr 3.7 ± 2.0 4.0 ± 2.3 0.6255 pDpyr 4.9 ± 2.9 11.2 ± 11.5 0.0013
When the ratio was compared between diseases, in PRE, We found different results for those measurements bone turnover in arthritis. However, very little is known between arthritis and normal controls, moreover about the pyridinium cross-links with regard to rates of between RA and OA. It has been reported that the fractions of Pyr and Dpyr were different between post-menopausal normal women and osteoporotic women, and the change in those fractions differed in osteoporotic women treated with oestrogen or bisphosphonates [19] . Ebeling et al. [25] have reported a lack of change in free Dpyr with menopause or with hormone replacement therapy, and no parallel changes in total Dpyr. Randall et al. [26 ] have reported that the free fraction of Dpyr showed a downward trend with disease severity in Paget's disease and the change in fractions of cross-links was different after treatment with pamidronate. They proposed a model where pyridinoline-containing collagen fragments are sequentially degraded to free pyridinolines with a rate-limiting step in the sequence between peptide forms and the free forms. Colwell and Eastell [27] have investi- of cross-links is produced in the kidney. It was proposed There was a significance in the ratio of Pyr (P = 0.0001) and that a renal mechanism may be present that contributes Dpyr (P = 0.0018) among the groups calculated by Kruskalto the free cross-link fraction seen in urine and is Wallis test. aP < 0.001, bP < 0.05 vs pre-menopausal normals; regulated by the metabolic state of bone turnover. Results from our present study show that both free and total forms of cross-links increase in as osteophytes and a subchondral sclerosis. Several studies have shown the elevated bone mineral densities post-menopausal normal women compared to premenopausal women. However, because the ratio of free in OA. There is a study that says spinal OA is associated with a generalized increase in bone mineral densities to total (free+peptide) increased in post-menopausal women, the degree of increase is greater in free form and a decreased excretion of collagen cross-links [29] . It suggests that spinal OA may be mediated by a than in peptide form in post-menopausal women. Our results on the effect of menopause are different from decreased bone turnover. Our observation of a decreased bone resorption in knee OA is in accordance with the previous results. In those results, the ratio of free to total forms of Pyr did not change [19] and that of Dpyr study of spinal OA. A study reported that Pyr and Dpyr in patients with did decrease in post-menopausal normals compared to pre-menopausal normals [19, 25] . The reason for the hip OA, knee OA and poly OA were similar, and did not differ from controls; however, they were significantly increase in free Dpyr in post-menopause observed in the present study may be complex; lower levels of free Dpyr higher in patients with radiographic end-stage OA than in patients with early OA [30] . Similarly, in this study, in pre-menopause is one reason.
Urinary pyridinoline cross-links have been extensively when OA patients were divided by radiographic grading, higher excretion of peptide and total Pyr and Dpyr was studied as markers of RA and OA. However, the comparison of free and peptide-bound forms of pyridinobserved in the more severe stage of OA. Therefore, peptide-bound cross-links may reflect the degree of joint oline cross-links has not been reported in arthritis. The present study suggests that the elevation in RA over involvement in OA.
Although a more precise examination is required, this normals is greater in Pyr than in Dpyr. All fractions of Pyr increase in RA in both pre-menopause and poststudy demonstrates the different changes in the excretion of urinary pyridinium cross-links between arthritis and menopause, except only free Pyr in post-menopause, whereas only free and total Dpyr in pre-menopausal normal controls, and between RA and OA. RA increased over normals. Pyr is distributed in most collagenous tissues, while Dpyr is more specifically
